ASCO 2022 Conference Coverage


 

ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Monotherapy in Advanced Mucosal and Cutaneous Melanoma

118 views
June 27, 2022
Comments 0
Login to view comments. Click here to Login